The race to acquire Life Technologies (LIFE) looks to be back in full swing again, with KKR...
Tuesday, March 12, 3:55 AM ETThe race to acquire Life Technologies (LIFE) looks to be back in full swing again, with KKR (KKR) reportedly mulling a joint bid with other private-equity firms for the biomedical laboratory equipment maker, which has a market cap of $10.5B. Strategic suitor Thermo Fisher Scientific (TMO) may renew its interest after backing off last month, while Danaher (DHR) is also sniffing around. A group led by Blackstone (BX) and Carlyle (CG) have been rumored to be in talks.
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles